For the success of directed mutagenesis experiments using homologous recombination in embryonic stem (ES) cells, it is essential that ES cells in culture retain the ability to populate the mouse germline. Culturing the cells in such a way as to maintain this ability presents a technical challenge. Several different methodologies have been employed but one that is commonly used is to culture the ES cells on a feeder layer of mouse primary embryonic fibroblasts (MEFs) (1, 2) .
The gene targeting technology also requires that ES cells in culture undergo drug selection to identify the cells that integrate the targeting construct Neomycin-resistance (neo 1 *) is the most commonly used dominant selectable gene for such experiments. To maintain a viable MEF feeder layer during drug selection it is necessary to prepare this layer with drug-resistant cells. Such neomycin-resistant feeder layers are conveniently prepared from transgenic mice expressing the neomycin-resistance gene.
To increase the flexibility of the targeting technology, a second dominant selectable marker, the hygromycin-resistance gene {hyg 1 *), has been employed. Hygromycin Bis an aminocyclitol antibiotic that acts by interfering with the ribosomal translocation and aminoacyl tRNA recognition leading to mistranslations (3). The hygromycin B resistance gene is a phosphotransferase that renders the drug inactive by adding a phosphate to position 4 (4, 5) . With the availability of this second selectable marker, one approach for the inactivation of both alleles of a gene has been to target the first allele with neo R and the second with hyg R (6, 10) . Additionally, when homozygous targeted mutations of closely linked genes are desired in one animal, crossing the individually targeted animals together to obtain recombinants becomes impractical. Instead, sequential targeting of the two linked genes with two selectable markers becomes the method of choice.
Previously there have been no published examples of ES cells targeted with the hyg R gene successfully repopulating the mouse germline and creating a strain of mice. However, such an experiment has been accomplished in the laboratory of Anton Bems, Netherlands Cancer Institute, thereby demonstrating the feasibility of using the hyg R gene for deriving targeted strains (Anton Berns, personal communication). In addition, we were interested in Dr Bern's strain as a possible source of hygromycinresistant MEFs. However, in that strain the hyg R gene is under the control of the endogenous Piml promoter, a promoter with limited endogenous expression and expected not to be active in fibroblasts. Thus, the aim of this study is to derive a hygromycinresistant transgenic strain of mice, optimal for the preparation of hygromycin-resistant MEF feeder layers, and to demonstrate the usefulness of these feeders for the selection of germline-capable ES cells. To achieve widespread and high level expression of the hyg R gene in transgenic mice we chose the 3-phosphoglycerate kinase (Pgkl) promoter (11) . Plasmid pPWL512 has a PGEM-llZf(+) backbone carrying a modified hyg R gene under the control of the mouse Pgkl promoter and polyadenylation signals ( Fig. 1 A) . A 2.0 kb Sfil and Xbal fragment containing these elements was isolated by electrophoresis, electroeluted, phenol-chloroform extracted, ethanol precipitated, and dissolved in 10 mM Tris, 0.1 mM EDTA pH 8.0. This DNA was microinjected into the male pronucleus of 234 C57BIV6J embryos according to standard procedures (12) . Embryo transfer to pseudopregnant females resulted in the birth of 31 mice.
Southern analysis of tail DNA, restricted with Ncol and probed with the injected 2.0 kb fragment (Fig. IB) , resulted in the identification of one male mouse with a single copy transgene insertion. The transgene is cut by Ncol and results in 5 and 3 kb bands on Southern analysis. The founder was bred to C57BL/6J females, and transgenic offspring were interbred to generate homozygous animals. Candidate homozygotes were initially detected by quantitative analysis of Southern band intensity using a BAS 1000 Bioimaging analyzer (Fuji Photo Film Co., Tokyo) (Fig. IB) . The endogenous Pgkl gene, which shares homology to the probe, results in 7 and 6 kb X chromosome bands, which after compensating for copy number based on the sex of the mouse, were used to standardize the DNA loading. In Figure IB , lanes 1, 3 and 4 demonstrate the presence of the transgene; 1 and 4 being from candidate homozygous mice. Homozygosity was confirmed by test mating candidates to C57BL/6J animals to generate at least 14 offspring all of which carried the transgene. Homozygous animals were then interbred to establish the strain C57BL/6J-TgN(pPWL512hyg)lEms, which is maintained by brother-sister mating. None of the homozygous transgenic animals has any apparent phenotype.
* To whom correspondence should be addressed A) To characterize the suitability of the C57BL/6J-TgN(pPWL512hyg)lEms strain for the preparation of hygromycin-resistant MEF feeder layers, heterozygous transgenic animals were intercrossed to produce an anticipated 1:2:1 ratio of wild-type, heterozygous and homozygous embryos, respectively. Thirteen to fifteen day fetuses were individually homogenized in 3 ml of feeder medium (10% Fetal Calf Serum in D-MEM) using a sterilized Brinkmann polytron homogenizer. Cell suspensions were plated in 15 ml of feeder medium/embryo in a T75 flask and incubated overnight at 37 °C with 5% CO2. The following day, cultures were trypsinized and replated in their original flasks to achieve maximal cell dispersal and to rid the cultures of debris. Confluency was typically achieved 2-3 days after the initial plating. At this point, cells from individual embryos were trypsinized, and aliquots replated in 24-well plates in non-selective medium. After at least 12 h, hygromycin B selection was started, with triplicate wells prepared for each embryo at various drug concentrations (hygromycin B, Calbiochem, La Jolla, CA) ( Table  1 ). The medium of each well was changed daily to simulate ES cell selection protocols. Observations were made daily but they did not vary after 1 day of selection nor among the triplicate wells. At the standard hygromycin B concentration used for ES cell selections, 0.2 mg/ml, 22/28 (79%) of the MEF wells from individual embryos showed no effect of the drug (Table 1) . Since this approximates the expected value of 75%, we deduce that both heterozygous and homozygous C57BL/6J-TgN(pPWL512-hyg)lEms embryos produce drug-resistant MEFs.
The concentration of hygromycin B required to achieve selection with some ES cell lines, or to select for multiple hyg R insertion events in one cell, may be higher than 0.2 mg/ml. Thus, a subset of resistant embryos was tested at 0.4 and/or 0.8 mg/ml. MEFs from all the resistant embryos that were retested showed higher levels of drug resistance, 15/22 (68%), supporting the conclusion that both heterozygous and homozygous C57BL/6J-TgN(pPWL512hyg)lEms embryos are highly drug resistant MEFs are usually further expanded and mitotically inactivated, by either mitomycin C or irradiation, prior to use as ES cell feeder layers (1,2) . To test whether this protocol affected our C57BL/6J-TgN(pPWL512hyg)lEms MEFs, cultures from three embryos were amplified until one embryo yielded -24 T75 flasks of confluent fibroblasts. At this point the cells were trypsinized, suspended in 40 ml of media in a 50 ml conical tube, and irradiated on ice with 3000 RADs (radiation absorbed dose) in a Shepard Mark 1 irradiator. The drug resistance of an aliquot of these irradiated fibroblasts was then compared to that of their unirradiated counterparts as described above. Table 1 shows that the drug-resistant phenotype was unaffected by this protocol.
Finally, MEFs from the C57BL/6J-TgN(pPWL512hyg)lEms strain of mice, prepared as described above, were used as feeder layers for the selection of hygromycin-resistant J1 (7) derived ES cells. These ES cells had previously been selected for neo R and were replated for electroporation with a hyg R based targeting vector. ES cell clones were isolated and characterized by Southern analysis to detect hyg R targeting constructs which had inserted into the genome by homologous recombination. Seven such clones were chosen for microinjection into blastocysts and five of these clones gave rise to chimeras. When test mated, chimeras from all five clones resulted in offspring that inherited the ES cell genome. Furthermore, each of the five clones generated two to three chimeras that gave 100% transmission of the ES genome. These results clearly demonstrate that high germline potential was retained during ES cell selection on our hygromycin feeders.
We have successfully derived a strain of homozygous hyg R transgenic mice from which highly drug-resistant MEFs can be prepared. These MEFs permit the maintenance of germline potential during hygromycin-resistant selection of ES cells. We are presently using the same approach to develop an improved strain of neomycin-resistant transgenic animals and a strain of puromycin-resistant animals; both are designed to increase the versatility of the gene targeting technology.
